Transient proteasome inhibition as a strategy to enhance lentiviral transduction of hematopoietic CD34+ cells and T lymphocytes: Implications for the use of low viral doses and large-size vectors-Reference-Cited by-同舟云学术

Transient proteasome inhibition as a strategy to enhance lentiviral transduction of hematopoietic CD34+ cells and T lymphocytes: Implications for the use of low viral doses and large-size vectors

Published:2011-12 Issue:3 Volume:156 Page:218-226
ISSN:0168-1656
Container-title:Journal of Biotechnology
language:en
Short-container-title:Journal of Biotechnology

Author:

Leuci Valeria,Mesiano Giulia,Gammaitoni Loretta,Cammarata Cristina,Capellero Sonia,Todorovic Maja,Jordaney Noela,Circosta Paola,Elia Angela,Lesnikova Marina,Georges George E.,Piacibello Wanda,Fagioli Franca,Cignetti Alessandro,Aglietta Massimo,Sangiolo Dario

Publisher

Elsevier BV

Subject

Applied Microbiology and Biotechnology,General Medicine,Biotechnology,Bioengineering

Reference58 articles.

1. Molecular evidence of lentiviral vector-mediated gene transfer into human self-renewing, multi-potent, long-term NOD/SCID repopulating hematopoietic cells;Ailles;Mol. Ther.,2002

2. Advances in gene therapy for ADA-deficient SCID;Aiuti;Curr. Opin. Mol. Ther.,2002

3. Gene therapy for immunodeficiency due to adenosine deaminase deficiency;Aiuti;N. Engl. J. Med.,2009

4. Ten years of gene therapy for primary immune deficiencies;Aiuti;Hematology Am. Soc. Hematol. Educ. Program,2009

5. Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning;Aiuti;Science (New York, NY),2002

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Materials promoting viral gene delivery;Biomaterials Science;2020

2. Targeting microglia with lentivirus and AAV: Recent advances and remaining challenges;Neuroscience Letters;2019-08

3. Proteasome Inhibition Increases the Efficiency of Lentiviral Vector-Mediated Transduction of Trabecular Meshwork;Investigative Opthalmology & Visual Science;2018-01-16

4. RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates fasudil as an antileukemic drug;Blood;2015-06-11

5. Mucopolysaccharidosis enzyme production by bone marrow and dental pulp derived human mesenchymal stem cells;Molecular Genetics and Metabolism;2015-04